Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

United States

Mayo Clinic in Arizona, Scottsdale, Arizona

Mayo Clinic in Florida, Jacksonville, Florida

Mayo Clinic in Rochester, Rochester, Minnesota